ImmunoGen, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 88   

Articles published

IMGN 6.17 -0.25 (-3.89%)
price chart
The case for Immunogen
Immunogen doesn't have an approved product yet. However, its anti-drug conjugate (ADC) technology is used in one approved cancer drug -- Roche's Kadcyla.
ImmunoGen Inc. (IMGN) Plunges 5.29% on October 11
ImmunoGen Inc. (IMGN) had a rough trading day for Wednesday October 11 as shares tumbled 5.29%, or a loss of $-0.37 per share, to close at $6.62.
ImmunoGen Inc. (IMGN) Plunges 7.1% on October 12
ImmunoGen Inc. (IMGN) had a rough trading day for Thursday October 12 as shares tumbled 7.1%, or a loss of $-0.47 per share, to close at $6.15.
Just the Facts on ImmunoGen, Inc. (IMGN)  StockNewsJournal
ImmunoGen, Inc. (IMGN) Insider Trading: BARROWS CRAIG sold 22450 Shares  Economic News
ImmunoGen Announces Closing of Public Offering of Common Stock, Including Full ...
WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (NASDAQ: IMGN) today announced the closing of its previously announced underwritten public offering of 16,675,000 shares of its common stock, including 2,175,000 shares sold pursuant to the ...
Brokers Opinions on: ImmunoGen, Inc. (IMGN)
ImmunoGen, Inc. on 6/29/2017 reported its EPS as $-0.51 with the analysts projecting the EPS of the stock as $-0.38.
Immunogen Inc (IMGN) A Look at Technical Overview  ExpertGazette
Analysts See $-0.27 EPS for ImmunoGen, Inc. (IMGN)  BZ Weekly
Hesitation to buy these stock might leave you disappointed: ImmunoGen, Inc ...
ImmunoGen, Inc. (NASDAQ:IMGN) market capitalization at present is $715.63M at the rate of $6.19 a share. The firm's price-to-sales ratio was noted 0.00 in contrast with an overall industry average of 90.29.
Going Through the Chart for ImmunoGen, Inc. (IMGN)  Economic News
Analyst Buzz: ImmunoGen, Inc. (IMGN)  FactsReporter
Traders Secrets on ImmunoGen, Inc. (IMGN), ContraVir Pharmaceuticals, Inc. (CTRV)
Investors who are keeping close eye on the stock of ImmunoGen, Inc. (NASDAQ:IMGN) established that the company was able to keep return on investment at - in the trailing twelve month while Reuters data showed that industry's average stands at 6.13 and ...
Insider Activity of ImmunoGen, Inc. (IMGN)
ImmunoGen, Inc. on 6/29/2017 reported its EPS as $-0.51 with the analysts projecting the EPS of the stock as $-0.38.
How Insiders and Institutions are Trading ImmunoGen, Inc. (IMGN)  StockNewsGazette
Stock Grabbing Investor's Attention: Immunogen Inc (IMGN)  Post Registrar
What the Technicals Say About ImmunoGen, Inc. (IMGN)
Latest evolution in the price of ImmunoGen, Inc. (NASDAQ:IMGN) stock has been one of the most talked about matter among the interested investors.
Analyst Opinion On How To Bet On ImmunoGen, Inc. (IMGN), Telefonaktiebolaget ...
ImmunoGen, Inc. has a consensus outperform rating from 9 Wall Street analysts, and the number of shares currently sold short amount to at least 11.61% of shares outstanding.